z-logo
Premium
Poster presentations (PP01–PP47)
Author(s) -
Zhu, M,
Wang, N,
Tsao, SW,
Tong, Y,
Feng, Y
Publication year - 2011
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.25877
Subject(s) - medicine
Poster Presentations: no. PP15aThis FREE journal suppl. entitled: Supplement: Abstracts of the Excellence in Oncology 2010 Conference 18–20 November 2010, Hilton Hotel, Athens, GreeceConference Theme: Cutting Edge Findings Into Clinical PracticeINTRODUCTION: Hepatocellular carcinoma is one of the most malignant cancers with dismal outcomes and the therapeutic strategies remain poor and far from developed. 3alpha,7beta-Dihydroxy-5beta-cholan-24-oic Acid N-(2-Sulfoethyl) amide (Tauroursodeoxycholic Acid, TUDCA) is currently in frequent used for protect the hepatocyte in several kinds of liver disorders including liver cancer. MicroRNA-21 (miR-21) overexpression was reported correlated with the high invasive property of cancer cells. PURPOSE: To profile the microRNA expression alteration in hepatocarcinoma cells with treatment of TUDCA and observe the effect of TUDCA in the invasion and metastasis of hepatocellular carcinoma. Material: Human hepatocellular carcinoma cell line with high metastatic property MHCC97-L. METHODS: We developed a sensitive microRNA on-chip array to detect the miRNAs expression profiling in MHCC97-L cells with or without TUDCA exposure. A quantitative real-time PCR method was introduced to validate the on-chip result. The cell migration was detected by wound healing the invasion chamber assay. Inhibition of miR-21 was conducted by introducing an antisense oligonucleotide complementary to the miRNA. RESULTS: Three microRNAs, let-7f, miR-21 and miR-23a were up-regulated in MHCC97-L with 100 lM TUDCA exposure for 48 hr. The result of the qPCR validates the increase of miR-21 expression in MHCC97-L cells treated with TUDCA comparing with the control. Increased cell migration was observed in MHCC97-L cells with 100 lM TUDCA exposure. Addition of miR-21 inhibitor attenuates the effect of TUDCA on MHCC97-L cell migration.link_to_OA_fulltextExcellence in Oncology: Cutting Edge Findings Into Clinical Practice, Athens, Greece, 18-20 November 2010. In International Journal of Cancer, 2011, v. 128 suppl. 1, p. 39, abstract no. PP15

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here